These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical use of midazolam].
    Author: Nishiyama T, Furuya C, Hanaoka K.
    Journal: Masui; 1997 Sep; 46(9):1172-8. PubMed ID: 9311206.
    Abstract:
    Midazolam is widely used in anesthesia. This paper shows characteristics of midazolam and how to use midazolam in clinical anesthesia. As a premedication, midazolam should be injected i. m. 15 min before entering an operating room in a dose of 0.04 mg.kg-1 to 0.08 mg.kg-1 according to the patient's age. For anesthesia induction, midazolam should be used together with barbiturate or propofol to take advantage of synergistic effects. Continuous infusion of midazolam in total intravenous anesthesia with fentanyl results in hemodynamic stability and good postoperative analgesia. During spinal or epidural anesthesia, i.v. midazolam of 0.05 mg.kg-1 has anti-anxietic and sedative effects. Midazolam inhibits awakening during cardiopulmonary bypass and it has little cardiodepressant effect. In aged, hepatic damaged or renal damaged patients, the effects of midazolam are slightly increased. Therefore, lower doses may be required in such patients. In conclusion, midazolam is usable in premedication, induction, maintenance in general anesthesia and in sedation in local anesthesia.
    [Abstract] [Full Text] [Related] [New Search]